Clinical Trial Update: Absorbable Drug-Eluting Lacrimal Sac Stent for Recurrent Chronic Dacryocystitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating an absorbable drug-eluting lacrimal sac stent for recurrent chronic dacryocystitis; the study is currently not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dacryocystitis

Drugs mentioned

• Absorbable Drug-Eluting Lacrimal Sac Stent

Snippet

Sponsor: Beijing Tongren Hospital | Conditions: Chronic Dacryocystitis | Phase 2 | Status: NOT_YET_RECRUITING